NewsRx

Search our medical news database

Fitch Ratings

Fitch Rates Dormitory Authority of New York's $483MM Mental Health Bonds 'A+'; Outlook Stable

Published in Health Insurance Week, March 29th, 2009

Fitch Ratings assigns an 'A+' rating to approximately $483 million Dormitory Authority of the State of New York (DASNY) mental health services facilities improvement revenue bonds, consisting of $443,675,000 series 2009A-1 and $39,115,000 series 2009B-1 (federally taxable). The bonds, which are being issued to refund outstanding variable-rate debt, are scheduled to be sold the week of March 9 through negotiation. Fitch also affirms the underlying 'A+' rating on about $3.8 billion in outstanding mental health services facilities improvement revenue bonds. The Rating Outlook is Stable.

The 'A+' rating for the mental health bonds is based on the credit quality of the State...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook